Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT03207191 · COMPLETED
Trial details
- NCT number
- NCT03207191
- Sponsor
- Philogen S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-02
- Primary completion
- 2020-03-26
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.